OpenAlex
PricingAboutJobs
Log inGet started
Work

Expanding access to newer medicines for people with type 2 diabetes in low-income and middle-income countries: a cost-effectiveness and price target analysis

HTML

Year: 2021
Type: article
Source: The Lancet Diabetes & Endocrinology
DOI: 10.1016/s2213-8587(21)00240-0
Author: †
Language: English

Topic: Diabetes Treatment and Management
Subfield: Endocrinology, Diabetes and Metabolism
Field: Medicine
Domain: Health Sciences
Keywords: type 2 diabetes, SGLT2 inhibitors, GLP-1 receptor agonists, insulin analogues, drug pricing, target price, cost-effectiveness, low- and middle-income countries, WHO Model List of Essential Medicines, sulfonylureas, insulin glargine, cardiovascular complications, heart failure, end-stage renal disease, microsimulation, access to medicines
SDG: Good health and well-being

Open Access status: green

Funders: National Institutes of Health, University of California, San Francisco
OpenAlex ID: W3197074662
FWCI: 6.644
Cites: 37
Cited by: 83
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Subscribe
Supporters
Legal
Privacy
Accessibility
Terms
Security